$NVGN Up to date company activities and other impo
Post# of 89734
Posted On: 06/21/2014 10:43:17 AM
$NVGN Up to date company activities and other important information about $NVGN
$NVGN
DD Notes ~ http://www.ddnotesmaker.com/NVGN
##### recent news/filings ~ source: finance.yahoo.com
Tue, 17 Jun 2014 11:00:00 GMT ~ Novogen and CanTx Announce Potency of Intra-Peritoneal Trx-1 Confirmed Against Chemo-Resistant Ovarian Cancer Stem Cells
- BOSTON, June 17, 2014 /PRNewswire/ -- Australian oncology drug development company Novogen Limited and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity. Based on the potency seen in animal models to date, and the potential to prevent recurrence, Novogen and CanTx believe that Intra-Peritoneal Trx-1 could be utilized as a first-line therapy for ovarian cancer. Trx-1 is being developed for the treatment of ovarian cancer, particularly for its ability to kill chemo-resistant ovarian cancer stem cells.
read full: http://finance.yahoo.com/news/novogen-cantx-a...00445.html
*********************************************************
Thu, 05 Jun 2014 20:54:45 GMT ~ 5 Reasons Why We Believe Novogen Is Poised For Success
read full: http://seekingalpha.com/article/2253263-5-rea...urce=yahoo
*********************************************************
Tue, 27 May 2014 13:00:06 GMT ~ Novogen rises 14.7%
read full: http://www.theflyonthewall.com/permalinks/ent...gen-rises-
*********************************************************
Tue, 27 May 2014 11:00:00 GMT ~ Novogen Identifies Highly Active Drug Candidates Against Prostate Cancer
- SYDNEY, May 27, 2014 /PRNewswire/ -- Novogen Limited (NASDAQ: NVGN, ASX:NRT), an oncology drug development company, today announced that it has achieved a key milestone with its super-benzopyran (SBP) drug program, having identified a number of SBP compounds with potent anti-cancer activity against human prostate cancer cells in vitro. As a result, Novogen has extended its preclinical SBP program to include prostate cancer as well as ovarian and brain cancers. Prostate cancer cells are highly resistant to chemotherapy and the few drugs approved for late-stage, hormone-resistant prostate cancer offer only modest improvements in survival. There is thus an urgent need to develop drugs specifically against prostate cancer that will prolong life to a meaningful degree for these advanced patients.
read full: http://finance.yahoo.com/news/novogen-identif...00275.html
*********************************************************
Sun, 04 May 2014 22:19:00 GMT ~ Children's Oncology Drug Alliance (CODA) Formed to Facilitate Development of Treatments for Childhood Cancers
- SYDNEY and COLUMBUS, Ohio, May 4, 2014 /PRNewswire/ -- Researchers and children's cancer advocates in Australia and the U.S. have formed a unique research and development alliance to facilitate development of treatments for children fighting neuroblastoma, the most common and fatal form of solid cancer affecting infants. The Children's Oncology Drug Alliance (CODA) unites the research and resources of the University of New South Wales (UNSW) in Australia and its commercialization arm, NewSouth Innovations;
read full: http://finance.yahoo.com/news/childrens-oncol...00601.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=NVGN&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=NVGN&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/NVGN/company-info
Ticker: $NVGN
OTC Market Place: Not Available
CIK code: 0001075880
Company name: Novogen Ltd.
Company website: http://www.novogen.com
Incorporated In: Australia
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/NVGN/filings
Latest financials: http://www.otcmarkets.com/stock/NVGN/financials
Latest news: http://www.otcmarkets.com/stock/NVGN/news - http://finance.yahoo.com/q/h?s=NVGN+Headlines
Major holdings: http://data.cnbc.com/quotes/NVGN/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=NVGN+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/NVGN.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=NVGN
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Novogen+Ltd.&x...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Novogen+Ltd.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.novogen.com
Alexa: http://www.alexa.com/siteinfo/http://www.novogen.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.novogen.com
Short Sales: http://www.otcmarkets.com/stock/NVGN/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/NVGN/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/NVGN/research
Historical Prices: http://finance.yahoo.com/q/hp?s=NVGN+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=NVGN+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=NVGN+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=NVGN+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=NVGN+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=NVGN+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=NVGN
Balance Sheet: http://finance.yahoo.com/q/bs?s=NVGN
Cash Flow: http://finance.yahoo.com/q/cf?s=NVGN+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/NVGN
Bloomberg: http://www.bloomberg.com/quote/NVGN:US
Morningstar: http://quotes.morningstar.com/stock/s?t=NVGN
Bussinessweek: http://investing.businessweek.com/research/st...icker=NVGN
Barchart: http://www.barchart.com/quotes/stocks/NVGN
OTC Short Report: http://otcshortreport.com/index.php?index=NVGN
Investopedia: http://www.investopedia.com/markets/stocks/NVGN/?wa=0
http://www.pennystocktweets.com/stocks/profile/NVGN
##### last known share structure ~ source: otcmarkets.com
Market Value: $303,528 a/o Jun 20, 2014
Shares Outstanding: 2,018,137 a/o Jan 03, 2011
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
##### business description ~ source: otcmarkets.com
DD Notes ~ http://www.ddnotesmaker.com/NVGN
$NVGN
DD Notes ~ http://www.ddnotesmaker.com/NVGN
##### recent news/filings ~ source: finance.yahoo.com
Tue, 17 Jun 2014 11:00:00 GMT ~ Novogen and CanTx Announce Potency of Intra-Peritoneal Trx-1 Confirmed Against Chemo-Resistant Ovarian Cancer Stem Cells
- BOSTON, June 17, 2014 /PRNewswire/ -- Australian oncology drug development company Novogen Limited and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity. Based on the potency seen in animal models to date, and the potential to prevent recurrence, Novogen and CanTx believe that Intra-Peritoneal Trx-1 could be utilized as a first-line therapy for ovarian cancer. Trx-1 is being developed for the treatment of ovarian cancer, particularly for its ability to kill chemo-resistant ovarian cancer stem cells.
read full: http://finance.yahoo.com/news/novogen-cantx-a...00445.html
*********************************************************
Thu, 05 Jun 2014 20:54:45 GMT ~ 5 Reasons Why We Believe Novogen Is Poised For Success
read full: http://seekingalpha.com/article/2253263-5-rea...urce=yahoo
*********************************************************
Tue, 27 May 2014 13:00:06 GMT ~ Novogen rises 14.7%
read full: http://www.theflyonthewall.com/permalinks/ent...gen-rises-
*********************************************************
Tue, 27 May 2014 11:00:00 GMT ~ Novogen Identifies Highly Active Drug Candidates Against Prostate Cancer
- SYDNEY, May 27, 2014 /PRNewswire/ -- Novogen Limited (NASDAQ: NVGN, ASX:NRT), an oncology drug development company, today announced that it has achieved a key milestone with its super-benzopyran (SBP) drug program, having identified a number of SBP compounds with potent anti-cancer activity against human prostate cancer cells in vitro. As a result, Novogen has extended its preclinical SBP program to include prostate cancer as well as ovarian and brain cancers. Prostate cancer cells are highly resistant to chemotherapy and the few drugs approved for late-stage, hormone-resistant prostate cancer offer only modest improvements in survival. There is thus an urgent need to develop drugs specifically against prostate cancer that will prolong life to a meaningful degree for these advanced patients.
read full: http://finance.yahoo.com/news/novogen-identif...00275.html
*********************************************************
Sun, 04 May 2014 22:19:00 GMT ~ Children's Oncology Drug Alliance (CODA) Formed to Facilitate Development of Treatments for Childhood Cancers
- SYDNEY and COLUMBUS, Ohio, May 4, 2014 /PRNewswire/ -- Researchers and children's cancer advocates in Australia and the U.S. have formed a unique research and development alliance to facilitate development of treatments for children fighting neuroblastoma, the most common and fatal form of solid cancer affecting infants. The Children's Oncology Drug Alliance (CODA) unites the research and resources of the University of New South Wales (UNSW) in Australia and its commercialization arm, NewSouth Innovations;
read full: http://finance.yahoo.com/news/childrens-oncol...00601.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=NVGN&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=NVGN&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/NVGN/company-info
Ticker: $NVGN
OTC Market Place: Not Available
CIK code: 0001075880
Company name: Novogen Ltd.
Company website: http://www.novogen.com
Incorporated In: Australia
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/NVGN/filings
Latest financials: http://www.otcmarkets.com/stock/NVGN/financials
Latest news: http://www.otcmarkets.com/stock/NVGN/news - http://finance.yahoo.com/q/h?s=NVGN+Headlines
Major holdings: http://data.cnbc.com/quotes/NVGN/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=NVGN+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/NVGN.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=NVGN
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Novogen+Ltd.&x...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Novogen+Ltd.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.novogen.com
Alexa: http://www.alexa.com/siteinfo/http://www.novogen.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.novogen.com
Short Sales: http://www.otcmarkets.com/stock/NVGN/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/NVGN/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/NVGN/research
Historical Prices: http://finance.yahoo.com/q/hp?s=NVGN+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=NVGN+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=NVGN+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=NVGN+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=NVGN+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=NVGN+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=NVGN
Balance Sheet: http://finance.yahoo.com/q/bs?s=NVGN
Cash Flow: http://finance.yahoo.com/q/cf?s=NVGN+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/NVGN
Bloomberg: http://www.bloomberg.com/quote/NVGN:US
Morningstar: http://quotes.morningstar.com/stock/s?t=NVGN
Bussinessweek: http://investing.businessweek.com/research/st...icker=NVGN
Barchart: http://www.barchart.com/quotes/stocks/NVGN
OTC Short Report: http://otcshortreport.com/index.php?index=NVGN
Investopedia: http://www.investopedia.com/markets/stocks/NVGN/?wa=0
http://www.pennystocktweets.com/stocks/profile/NVGN
##### last known share structure ~ source: otcmarkets.com
Market Value: $303,528 a/o Jun 20, 2014
Shares Outstanding: 2,018,137 a/o Jan 03, 2011
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
##### business description ~ source: otcmarkets.com
DD Notes ~ http://www.ddnotesmaker.com/NVGN
(0)
(0)